Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,639.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 1,851.00
  • 52 Week Low: 1,191.00
  • Currency: UK Pounds
  • Shares Issued: 209.57m
  • Volume: 668,306
  • Market Cap: £3,434.90m
  • RiskGrade: 125
  • Beta: 0.00

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Said Darwazah
Chairman: Victoria Hull
Deputy CEO: Khalid Nabilsi
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Tobias Hestler
Senior Independent Director: Douglas Hurt
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 10 Portman Square, London, United Kingdom, W1H 6AZ
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,639.00p
Change Today -1.00p
% Change -0.06 %
52 Week High 1,851.00
52 Week Low 1,191.00
Volume 668,306
Shares Issued 209.57m
Market Cap £3,434.90m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average74.3% below the market average
31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average31.71% above the sector average
Price Trend
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average
Income
38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average38.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average42.16% above the market average
3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average3.45% above the sector average

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 13-Aug-26 19-Mar-26
Paid 17-Sep-26 30-Apr-26
Amount 38.00¢ 48.00¢

Trades for 17-Aug-2026

Time Volume / Share Price
11:09 275 @ 1,638.00p
11:09 160 @ 1,638.00p
11:09 64 @ 1,638.00p
11:09 35 @ 1,638.00p
11:09 24 @ 1,638.00p

HIK Key Personnel

CEO Said Darwazah
Chair Victoria Hull

Top of Page